investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

CRC Tier 1 - Determining why mutations of the metabolic enzyme isocitrate dehydrogenase cause leukemias and brain cancers

Tak Mak

0 Collaborator(s)

Funding source

Canadian Institutes of Health Research (CIHR)

Tak Mak

University of Toronto

Toronto, Canada

Related projects

James Kochenderfer

Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor

Leukaemia

Hematology and hematologic malignancies

Aaron David Schimmer

Targeting the mitochondrial proteasome, ClpP, in AML

Leukaemia

Michael R Green

Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

H Leighton Grimes

Developing Novel STAT5 Protein Inhibitors for Treatment of Leukemias

Leukaemia

Hematology and hematologic malignancies Pathology

Daniel Fowler

Combination Gene Therapy and Th1/Th2 Therapy

Leukaemia

Hematology and hematologic malignancies

Aaron David Schimmer

Targeting mitochondrial translation as a novel therapeutic strategy for AML

Leukaemia

Brent Williams

Immunotherapy of leukemic stem cells

Leukaemia

Katherine L B Borden

Molecular Mechanisms of eIF4E mediated transformation

Leukaemia

Hematology and hematologic malignancies Pathology

Peter Aplan

Activation of Proto-Oncogenes by Chromosomal Translocation

Leukaemia

Hematology and hematologic malignancies Pathology